Consolidated Statement Of Comprehensive Income

Modalis Therapeutics Corporation - Filing #7337841

Concept 2024-01-01 to
2024-03-31
2023-01-01 to
2023-03-31
Consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-457,936,000 JPY
-532,371,000 JPY
Other comprehensive income
Foreign currency translation adjustment
-428,000 JPY
1,250,000 JPY
Other comprehensive income
-428,000 JPY
1,250,000 JPY
Comprehensive income
-458,364,000 JPY
-531,121,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-458,364,000 JPY
-531,121,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.